A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil

European Journal of Cancer

Volumn 30, Issue 10, 1994, Pages 1517-1522

  Beck, A ^a   Etienne, M C ^a   Cheradame S ^a   Fischel, J L ^a   Formento, P ^a   Renee N ^a   Milano, G ^a  

^a CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; THYMIDYLATE SYNTHASE;

ARTICLE; ASSAY; CANCER; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SENSITIVITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL LINE;

BREAST NEOPLASMS; DIGESTIVE SYSTEM NEOPLASMS; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMAN; OXIDOREDUCTASES; PROGNOSIS; SUPPORT, NON-U.S. GOV'T; THYMIDYLATE SYNTHASE; TUMOR CELLS, CULTURED;

EID: 0028097137     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(94)00216-R     Document Type: Article

References (34)

1. Continuous infusion high-dose leucovorin with 5-fluorouracil and cisplatin for untreated stage IV carcinoma of the head and neck
2. Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer
3. Fluorinated pyrimidines
4. Biochemical modulation of fluorouracil with leucovorin. Confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer
5. Modulation of fluorouracil in patients with advanced colorectal cancer. Evidence in terms of response rate
6. A less toxic regimen of 5-fluorouracil and high-dose folinic acid for advanced gastrointestinal adenocarcinomas
7. Clinical pharmacology of 5-fluorouracil
8. Metabolism and mechanism of action of 5-fluorouracil
9. Studies on resistance against 5-fluorouracil. Enzymes of the uracil pathway during development of resistance
10. Mechanisms of sensitivity and resistance of murine tumors to 5-fluorouracil
11. Biochemical determinants of responsiveness to 5-fluorouracil and its derivatives in xenografts of human colorectal adenocarcinoma in mice
12. Biochemical characterization of fluoropyrimidine-resistant murine leukemic cell lines
13. Decreased folylpolyglutamate synthetase expression: a novel mechanism of fluorouracil resistance
14. Thymidilate synthase gene amplification in a colon tumor resistant to fluoropyrimidine chemotherapy
15. Thymidylate synthase expression is an independent predictor of survival/disease free survival in patients with rectal cancer
16. Thymidylate synthase gene expression predicts response of primary gastric cancer
17. Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5t́-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes
18. Multifactorial resistance of 5-fluorouracil in human colon cancer cell lines
19. Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedules
20. Enzymes of uracil catabolism in normal and neoplastic human tissues
21. Biochemical determinants of tumor sensitivity to 5-fluoro-2t́ deoxyuridilate, 2t́ deoxyuridilate and thymidilate synthase
22. Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion
23. Rapid catabolism of 5-fluorouracil in freshly isolated rat hepatocytes as analyzed by high-performance liquid chromatography
24. 4 Pteglu assays
25. Improved measurement of thymidylate synthetase activity by a modified tritium-release assay
26. Evaluation of a tetrazolium-based semi-automated colorimetric assay in assessment of chemosensitivity testing
27. Folk acid, 1991. An update with new recommended daily allowances
28. Elevation of thymidylate synthase following 5-fluorouracil treatment is prevented by the addition of leucovorin in murine colon tumors
29. Immunological quantification of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil-sensitive and -resistant human cancer cell lines
30. Quantification of thymidylate synthase, dihydrofolate reductase and D-T diaphorase gene expression in human tumors using the polymerase chain reaction
31. No effect of dose, hepatic function, or nutritional status on 5FU clearance following continuous (5-day), 5FU infusion
32. Distribution and inhibition of dihydrouracil dehydrogenase activities in human tissues using 5-fluorouracil as a substrate
33. Decreased catabolism of fluorouracil in peripheral blood mononuclear cells during combination therapy with fluorouracil, leucovorin and interferon α-2a
34. Potentiation of 5-fluorouracil efficacy by the dihydrouracil dehydrogenase inhibitor, 5 benzyloxybenzyluracil